Abstract
Artesunate reduces mortality and should now be the treatment of choice in severe malaria in adults: good news for countries in our region, but registration in Australia must wait.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
